Swiss specialty chemicals producer Clariant reported third-quarter sales of CHF 968.8 million, representing 5.6% growth in local currencies. However, its adjusted EBITDA margin declined to 15.6%, highlighting continued profitability pressure. The company cited volatile trading conditions while confirming its full-year guidance. The results illustrate how revenue growth can coexist with weaker margins across the global chemicals industry in 2026. Overall.
Clariant Sales Rise 5.6% as Profit Margin Narrows
Continue Reading
More coverage on the subjects, companies and places discussed in this article.
Explore this category
Discover more from Bioplastics News
Subscribe to get the latest reporting in your inbox.
